Theodore M Hester (Ted)

Partner

Translate this page Share this page Print this page
Theodore Hester

WASHINGTON, D.C.
T: +1 202 626 2901
F: +1 202 626 3737

E-mail
Profile   |   Matters   |   Recognition   |   News & Insights

Representative Experience

  • Representing Toyota in investigations and hearings by the House Energy and Commerce Committee, the House Oversight and Government Reform Committee, and the Senate Commerce, Science and Transportation Committee relating to allegations of unintended acceleration.

  • Providing advice and counsel with respect to congressional oversight activity to the leading pharmaceutical industry trade association and to leading companies in the pharmaceutical, medical device, food processing, healthcare, telecommunications, logistics, insurance and oil industries.

  • Representing major pharmaceutical and medical device companies before the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee, the House Oversight and Government Reform Committee, the Senate Finance Committee, and the Senate Aging Committee in connection with investigations relating to the interaction of these companies with the FDA in the drug and device approval process, the disclosure by those companies of clinical trial data, their release of product performance data, their marketing practices, including drug pricing issues, off label use, direct-to-consumer advertising, and sampling programs, and their relationships with physicians, professional organizations and academic institutions.

  • Representing the Georgia Department of Agriculture in an investigation relating to the presence of salmonella in peanut butter.

  • Representing a multinational manufacturer in an Oversight and Investigations Subcommittee investigation relating to the safety of infant formula.

  • Representing a Big Four accounting firm in a Senate Finance Committee investigation of a University’s handling of federal funds.

  • Representing a global consulting firm in connection with an Oversight and Government Reform Committee investigation of executive compensation practices, and a House Financial Services Committee hearing on federal oversight of insurance.

  • Representing a health insurer in a Senate Commerce Committee investigation of out-of-network coverage.

  • Representing a major government contractor in connection with investigations of conflicts of interest at the National Institutes of Health by the House Energy and Commerce Committee and the Inspector General of the Department of Health and Human Services.

  • Representing a healthcare products manufacturer in connection with an investigation of active pharmaceutical ingredients imported from China. 

  • Representing a beverage manufacturer in an Oversight and Investigations Subcommittee inquiry relating to chemical or microbiological contamination.

  • Representing a Medicare insurance company in connection with a request for information from the House Energy and Commerce Committee and the Senate Aging Committee regarding marketing practices in the Medicare Advantage program.

  • Representing a nationwide retail grocery chain in an Oversight and Investigations Subcommittee investigation of meat packaging.

  • Representing a medical device manufacturer in investigations relating to the use of its products in V.A. hospitals by both the House and Senate Veterans’ Affairs Committees.

  • Represented a property casualty insurance company in connection with a House Financial Services Committee investigation about insurance coverage issues growing out of losses sustained from Hurricane Katrina.

  • Represented a major parcel carrier before the House Energy and Commerce Committee and the Senate’s Permanent Subcommittee on Investigations relating to the shipment of counterfeit or unsafe pharmaceuticals ordered over the internet.

  • Represented Purdue Pharma in connection with five separate congressional hearings and a two-year investigation by the Government Accountability Office on the abuse and diversion of the company's pain medication, OxyContin®.

  • Represented Bridgestone/Firestone, Inc. in connection with congressional investigations into rollover accidents by both the House Energy and Commerce Committee and the Senate Commerce, Science, and Transportation Committee.

  • Represented the Independent Review Committee of the Statue of Liberty-Ellis Island Foundation in connection with investigations of the Foundation and the National Park Service by the Senate Finance Committee and the Department of the Interior Inspector General.

  • Represented The SCOOTER Store, Ltd. in a Senate Finance Committee investigation of Medicare reimbursement of motorized wheelchairs.

  • Represented Metabolife International before the Government Accountability Office during its investigation into the company's health-related call records regarding its dietary supplement, Metabolife 356, and before the House Energy and Commerce Committee in its investigation of dietary supplements containing ephedra.

  • Represented the Georgia Amateur Athletic Foundation, the entity that organized Atlanta's bid for the 1996 Summer Olympic Games, before the House Energy and Commerce Committee in an investigation focused on the Olympic bid process.

  • Represented the nation's leading supplier of flu vaccine to health care providers in an investigation relating to the distribution of flu vaccine.

  • Coordinated preparation of the July 2000 report issued by the Nunn-Wolfowitz Task Force, led by former Senator Sam Nunn and then-Ambassador Paul Wolfowitz. In the wake of congressional investigations into allegations that space launch technology was improperly transferred by certain U.S. companies to China, the Task Force was commissioned by the Board of Directors of Hughes Electronics to help review and strengthen the company's export compliance program. The Nunn-Wolfowitz report recommended industry "best practices" guidelines regarding export compliance programs.